Avorelin
Alternative Names: EP 23904; MF 6001Latest Information Update: 11 Dec 2007
At a glance
- Originator Europeptides
- Class
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Endometriosis; Prostate cancer
Most Recent Events
- 11 Dec 2007 Discontinued - Phase-II for Breast cancer in Europe (Implant)
- 11 Dec 2007 Discontinued - Phase-II for Endometriosis in Europe (Implant)
- 11 Dec 2007 Discontinued - Phase-II for Prostate cancer in Europe (Implant)